Search Results
Dr. Tasian on Challenges in Treating Pediatric Patients With Ph-Like ALL
Dr. Tasian on Frontline Therapy for Pediatric Patients With Ph-Like ALL
Dr. Tasian on the Heterogeneity of Ph-Like ALL in Pediatric Patients
Exploring novel treatment strategies for Ph-like ALL
Dr Sarah Tasian Discusses Challenges to Overcome When New Therapies Come to Market for Pediatric AML
Evolving therapy of Ph+ and Ph-like ALL
Dr Sarah Tasian Highlights Challenges With Improving Outcomes in Pediatric AML
Challenges in treating pediatric leukemias
Diagnostic testing modalities for Ph-like ALL
Sarah Tasian, MD, on Advances, Challenges in Pediatric Hematologic Oncology at ASH 2022
Diagnostic strategies for Ph-like ALL
Areas Under Investigation in Ph-Like ALL
